Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections

Clinical trial NCT05639647 · RECRUITING

Trial details

NCT number: NCT05639647
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gram-negative Bacterial Infections

Start date: 2023-04-18
Primary completion: 2027-03-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.